Deutsche Bank
IMGN

Deutsche Bank’s Immunogen Inc IMGN Stock Holding History

Deutsche Bank’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,065,880
Closed -$31.6M – 3711
2023
Q4 		$31.6M Buy
1,065,880
+840,814
+374% +$16.7M 0.02% 660
2023
Q3 		$3.57M Sell
225,066
-3,079,661
-93% -$51.2M ﹤0.01% 1140
2023
Q2 		$62.4M Buy
3,304,727
+226,883
+7% +$2.68M 0.03% 458
2023
Q1 		$11.8M Buy
3,077,844
+40,284
+1% +$172K 0.01% 914
2022
Q4 		$15.1M Buy
3,037,560
+31,075
+1% +$168K 0.01% 840
2022
Q3 		$14.4M Sell
3,006,485
-24,509
-0.8% -$129K 0.01% 850
2022
Q2 		$13.6M Buy
3,030,994
+85,277
+3% +$370K 0.01% 890
2022
Q1 		$14M Buy
2,945,717
+1,104,077
+60% +$6.11M 0.01% 951
2021
Q4 		$13.7M Buy
1,841,640
+6,194
+0.3% +$38.5K 0.01% 988
2021
Q3 		$10.4M Sell
1,835,446
-12,747
-0.7% -$73.7K ﹤0.01% 1144
2021
Q2 		$12.2M Sell
1,848,193
-1,145,979
-38% -$7.99M 0.01% 1093
2021
Q1 		$24.3M Buy
2,994,172
+141,726
+5% +$1.16M 0.01% 836
2020
Q4 		$18.4M Buy
2,852,446
+1,073,055
+60% +$6.26M 0.01% 817
2020
Q3 		$6.41M Buy
1,779,391
+962,081
+118% +$3.88M ﹤0.01% 1151
2020
Q2 		$3.76M Sell
817,310
-498,553
-38% -$2.12M ﹤0.01% 1452
2020
Q1 		$4.49M Buy
1,315,863
+1,191,452
+958% +$5.21M ﹤0.01% 1310
2019
Q4 		$634K Sell
124,411
-97,547
-44% -$331K ﹤0.01% 2612
2019
Q3 		$535K Sell
221,958
-710,283
-76% -$1.89M ﹤0.01% 2650
2019
Q2 		$2.02M Sell
932,241
-1,435,774
-61% -$3.4M ﹤0.01% 2384
2019
Q1 		$6.42M Buy
2,368,015
+1,125,772
+91% +$4.88M ﹤0.01% 1683
2018
Q4 		$5.96M Buy
1,242,243
+321,783
+35% +$1.95M ﹤0.01% 1638
2018
Q3 		$8.72M Buy
920,460
+575,101
+167% +$5.53M ﹤0.01% 1756
2018
Q2 		$3.36M Sell
345,359
-618,288
-64% -$6.52M ﹤0.01% 2597
2018
Q1 		$10.1M Buy
963,647
+296,143
+44% +$2.93M ﹤0.01% 1608
2017
Q4 		$4.28M Sell
667,504
-356,661
-35% -$2.2M ﹤0.01% 2145
2017
Q3 		$7.83M Buy
1,024,165
+56,550
+6% +$376K 0.01% 1621
2017
Q2 		$6.88M Sell
967,615
-797,406
-45% -$3.65M ﹤0.01% 1684
2017
Q1 		$6.83M Sell
1,765,021
-164,332
-9% -$480K 0.01% 1499
2016
Q4 		$3.93M Buy
1,929,353
+362,397
+23% +$728K ﹤0.01% 1809
2016
Q3 		$4.2M Buy
1,566,956
+104,752
+7% +$305K ﹤0.01% 1859
2016
Q2 		$4.5M Buy
1,462,204
+1,205,536
+470% +$7.56M ﹤0.01% 1836
2016
Q1 		$2.19M Sell
256,668
-37,241
-13% -$315K ﹤0.01% 2308
2015
Q4 		$3.99M Sell
293,909
-257,812
-47% -$3.17M ﹤0.01% 1954
2015
Q3 		$5.29M Buy
551,721
+78,782
+17% +$1.15M ﹤0.01% 1768
2015
Q2 		$6.8M Sell
472,939
-41,527
-8% -$456K ﹤0.01% 1599
2015
Q1 		$4.6M Sell
514,466
-26,055
-5% -$189K ﹤0.01% 1848
2014
Q4 		$3.3M Buy
540,521
+138,448
+34% +$1.27M ﹤0.01% 2285
2014
Q3 		$4.26M Sell
402,073
-191,054
-32% -$2.16M ﹤0.01% 1954
2014
Q2 		$7.03M Buy
593,127
+230,300
+63% +$2.89M ﹤0.01% 1578
2014
Q1 		$5.42M Sell
362,827
-12,502
-3% -$197K ﹤0.01% 1766
2013
Q4 		$5.5M Sell
375,329
-158,477
-30% -$2.44M ﹤0.01% 1698
2013
Q3 		$9.08M Sell
533,806
-39,331
-7% -$691K 0.01% 1393
2013
Q2 		$9.51M Buy
+573,137
New +$9.29M 0.01% 1268

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deutsche Bank's IMGN Position: Q1 2024 in Review

Deutsche Bank sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,065,880 shares — an estimated $31.6M sold.

Deutsche Bank first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $62.4M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Deutsche Bank reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Deutsche Bank sold 1,065,880 Immunogen Inc shares in Q1 2024, an estimated $31.6M.
  • Deutsche Bank first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Deutsche Bank's Immunogen Inc position peaked at $62.4M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.